Canada Life Portfolio holdings
AUM
$63.1B
This Quarter Return
+10.02%
1 Year Return
+22.24%
3 Year Return
+92.16%
5 Year Return
+162.31%
10 Year Return
+335.82%
AUM
$38B
AUM Growth
+$38B
(+8%)
Cap. Flow
-$28.6M
Cap. Flow
% of AUM
-0.08%
Top 10 Holdings %
Top 10 Hldgs %
19.42%
Holding
2,424
New
34
Increased
1,213
Reduced
837
Closed
77
Top Buys
| 1 |
Stellantis
STLA
|
$59.5M |
| 2 |
Exelon
EXC
|
$48.6M |
| 3 |
Prologis
PLD
|
$38.6M |
| 4 |
Johnson & Johnson
JNJ
|
$30.8M |
| 5 |
Cigna
CI
|
$30.1M |
Top Sells
| 1 |
Texas Instruments
TXN
|
$63.6M |
| 2 |
Allstate
ALL
|
$40.9M |
| 3 |
Gilead Sciences
GILD
|
$34.7M |
| 4 |
Oracle
ORCL
|
$32.3M |
| 5 |
Meta Platforms (Facebook)
META
|
$30.7M |
Sector Composition
| 1 | Technology | 22.68% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 13.83% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Industrials | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOOR
2001
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $93K | ﹤0.01% |
1,148
| – | – |
|
2002
Ginkgo Bioworks
DNA
$663M
| $92K | ﹤0.01% |
54,098
+23,482
| +77% | +$39.9K |
|
2003
Horizon Bancorp
HBNC
$848M
| $92K | ﹤0.01% |
6,040
+2,035
| +51% | +$31K |
|
2004
Parsons
PSN
$8.51B
| $92K | ﹤0.01% |
1,967
| – | – |
|
2005
Twist Bioscience
TWST
$1.59B
| $92K | ﹤0.01% |
3,867
+848
| +28% | +$20.2K |
|
2006
Montrose Environmental
MEG
$1.03B
| $91K | ﹤0.01% |
2,047
+476
| +30% | +$21.2K |
|
|
HEES
2007
DELISTED
H&E Equipment Services
HEES
| $90K | ﹤0.01% |
1,966
| – | – |
|
2008
Kearny Financial
KRNY
$419M
| $90K | ﹤0.01% |
8,793
+2,961
| +51% | +$30.3K |
|
2009
IAMGOLD
IAG
$5.49B
| $88K | ﹤0.01% |
34,544
+13,080
| +61% | +$33.3K |
|
2010
Stitch Fix
SFIX
$699M
| $86K | ﹤0.01% |
27,580
+14,233
| +107% | +$44.4K |
|
|
EVOP
2011
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $85K | ﹤0.01% |
2,488
| – | – |
|
2012
Camden National
CAC
$679M
| $83K | ﹤0.01% |
1,979
+498
| +34% | +$20.9K |
|
2013
Akero Therapeutics
AKRO
$3.61B
| $82K | ﹤0.01% |
1,486
+901
| +154% | +$49.7K |
|
2014
Krystal Biotech
KRYS
$4.38B
| $81K | ﹤0.01% |
1,013
| – | – |
|
2015
NovaGold Resources
NG
$2.71B
| $81K | ﹤0.01% |
13,561
| – | – |
|
2016
PJT Partners
PJT
$4.23B
| $81K | ﹤0.01% |
1,094
| – | – |
|
2017
Ennis
EBF
$468M
| $80K | ﹤0.01% |
3,616
+760
| +27% | +$16.8K |
|
2018
Revolution Medicines
RVMD
$7.44B
| $80K | ﹤0.01% |
3,356
+830
| +33% | +$19.8K |
|
2019
BioNTech
BNTX
$24B
| $79K | ﹤0.01% |
524
+60
| +13% | +$9.05K |
|
2020
TG Therapeutics
TGTX
$4.91B
| $79K | ﹤0.01% |
6,682
| – | – |
|
2021
Flushing Financial
FFIC
$459M
| $78K | ﹤0.01% |
4,000
+1,340
| +50% | +$26.1K |
|
|
RVNC
2022
DELISTED
Revance Therapeutics, Inc.
RVNC
| $78K | ﹤0.01% |
4,196
+874
| +26% | +$16.2K |
|
|
TUP
2023
DELISTED
Tupperware Brands Corporation
TUP
| $78K | ﹤0.01% |
18,809
-30,151
| -62% | -$125K |
|
2024
Tilray
TLRY
$1.33B
| $77K | ﹤0.01% |
28,292
+4,626
| +20% | +$12.6K |
|
2025
Midland States Bancorp
MSBI
$393M
| $75K | ﹤0.01% |
2,812
+770
| +38% | +$20.5K |
|